InterCure to Participate in ROTH Capital’s 34th Annual Conference

NEW YORK, TORONTO, and HERZLIYA, Israel, March 15, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in ROTH Capital’s 34th Annual Conference, taking place March 15, 2022.

Mr. Rabinovitch will take part in the One-on-One Fireside Chat: Tuesday, March 15th, 2022 at 9:30 AM PT.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

Contact:

InterCure Ltd.Amos Cohen, Chief Financial Officer[email protected]

You May Also Be Interested In

• InterCure Ltd. Announces 1-for-5 Reverse Share Split
• Canadian Securities Exchange Welcomes Listing of Althea Copper Corp
• Magnus Technologies Releases July 2026 Diesel Fuel Snapshot, Highlighting Second Straight Monthly Drop in Diesel Prices, Warns Fuel Surcharges May Not Be Keeping Pace